Matrixx Initiatives Inc. (NASDAQ: MTXX) has no real fresh news. This week it did elect a new CEO but this morning there was a stock tout from one of the Najarian brothers of OptionsMonster.com on CNBC. What was noted is the options trading picked up this week as institutions are betting that the Zicam nasal spray woes will get resolved. He also noted that would bring significant upside if the company can resolve this. So far we have seen a 10.2% jump to $5.95. As a reminder, this was a $15 to $20 stock before the FDA made them take this off the shelves. At 9:15 AM EST we have already seen 500,000 shares trade hands and the average volume is 1.7 million shares. -JON OGG
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment